Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of VVZ-149 Injections for Low Back Pain
KCT0010614Phase 2Not yet recruiting
- Sponsor
- Vivozon
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lumbodynia (LBP) comparing VVZ-149 injection with Placebo injection (2 arms). Planned start Jun 2025; status: not yet recruiting.
02
Drugs
opiranserin
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on KCT0010614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010614.